BRPI0813002A2 - marcadores preditivos para o câncer ovariano - Google Patents

marcadores preditivos para o câncer ovariano

Info

Publication number
BRPI0813002A2
BRPI0813002A2 BRPI0813002A BRPI0813002A BRPI0813002A2 BR PI0813002 A2 BRPI0813002 A2 BR PI0813002A2 BR PI0813002 A BRPI0813002 A BR PI0813002A BR PI0813002 A BRPI0813002 A BR PI0813002A BR PI0813002 A2 BRPI0813002 A2 BR PI0813002A2
Authority
BR
Brazil
Prior art keywords
ovarian cancer
predictive markers
predictive
markers
ovarian
Prior art date
Application number
BRPI0813002A
Other languages
English (en)
Inventor
C Mansfield Brian
P Bertenshaw Greg
Yip Ping
Amonkar Suraj
Original Assignee
Correlogic Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Correlogic Systems Inc filed Critical Correlogic Systems Inc
Publication of BRPI0813002A2 publication Critical patent/BRPI0813002A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G01N33/5759Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites involving compounds localised on the membrane of tumour or cancer cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/50Determining the risk of developing a disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
BRPI0813002A 2007-06-29 2008-06-30 marcadores preditivos para o câncer ovariano BRPI0813002A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94725307P 2007-06-29 2007-06-29
US3794608P 2008-03-19 2008-03-19
PCT/US2008/068845 WO2009006439A1 (en) 2007-06-29 2008-06-30 Predictive markers for ovarian cancer

Publications (1)

Publication Number Publication Date
BRPI0813002A2 true BRPI0813002A2 (pt) 2017-05-02

Family

ID=40161028

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0813002A BRPI0813002A2 (pt) 2007-06-29 2008-06-30 marcadores preditivos para o câncer ovariano

Country Status (10)

Country Link
US (5) US8664358B2 (pt)
EP (2) EP2171453A4 (pt)
JP (1) JP2010532484A (pt)
KR (2) KR101262202B1 (pt)
CN (1) CN101855553B (pt)
BR (1) BRPI0813002A2 (pt)
CA (1) CA2691980C (pt)
MY (1) MY150234A (pt)
SG (1) SG182976A1 (pt)
WO (1) WO2009006439A1 (pt)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0307428D0 (en) * 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20060078893A1 (en) * 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20050221339A1 (en) * 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
US7968287B2 (en) * 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
WO2007081385A2 (en) 2006-01-11 2007-07-19 Raindance Technologies, Inc. Microfluidic devices and methods of use in the formation and control of nanoreactors
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
EP2530167A1 (en) 2006-05-11 2012-12-05 Raindance Technologies, Inc. Microfluidic Devices
EP2077912B1 (en) 2006-08-07 2019-03-27 The President and Fellows of Harvard College Fluorocarbon emulsion stabilizing surfactants
WO2008097559A2 (en) 2007-02-06 2008-08-14 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
US8592221B2 (en) 2007-04-19 2013-11-26 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
EP2153234A2 (en) 2007-05-11 2010-02-17 The Institutes for Pharmaceutical Discovery, LLC Methods for early diagnosis of kidney disease
JP2008295328A (ja) 2007-05-30 2008-12-11 Fujifilm Corp 卵巣癌の検出方法、及び抑制方法
US8664358B2 (en) 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer
EP2088204A1 (en) * 2008-02-05 2009-08-12 Adnagen AG Method and kit for diagnosing or controlling the treatment of ovarian cancer
WO2009129569A1 (en) * 2008-04-23 2009-10-29 Healthlinx Limited An assay to detect a gynecological condition
US12038438B2 (en) 2008-07-18 2024-07-16 Bio-Rad Laboratories, Inc. Enzyme quantification
EP4047367A1 (en) 2008-07-18 2022-08-24 Bio-Rad Laboratories, Inc. Method for detecting target analytes with droplet libraries
WO2010111231A1 (en) 2009-03-23 2010-09-30 Raindance Technologies, Inc. Manipulation of microfluidic droplets
CN103694332B (zh) * 2009-07-07 2017-07-11 清华大学 一种新的肿瘤标志物
CN101942017B (zh) * 2009-07-07 2013-08-14 清华大学 一种新的肿瘤标志物
US10520500B2 (en) 2009-10-09 2019-12-31 Abdeslam El Harrak Labelled silica-based nanomaterial with enhanced properties and uses thereof
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル,インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US20140148348A1 (en) 2010-01-13 2014-05-29 Christine Kuslich Dectection of gastrointestinal disorders
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
EP4484577A3 (en) 2010-02-12 2025-03-26 Bio-Rad Laboratories, Inc. Digital analyte analysis
EP3070474A3 (en) * 2010-02-26 2016-12-07 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
EP2542696B1 (en) 2010-03-01 2016-09-28 Caris Life Sciences Switzerland Holdings GmbH Biomarkers for theranostics
JP2013526852A (ja) 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
US9562897B2 (en) 2010-09-30 2017-02-07 Raindance Technologies, Inc. Sandwich assays in droplets
CA2818593A1 (en) * 2010-10-22 2012-04-26 Vermillion, Inc. Prognostic biomarkers in patients with ovarian cancer
CN102147412A (zh) * 2010-12-31 2011-08-10 深圳市亚辉龙生物科技有限公司 一种测定抗蛋白酶3抗体IgG的方法及试剂装置
EP3412778A1 (en) 2011-02-11 2018-12-12 Raindance Technologies, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
KR20140024860A (ko) * 2011-02-24 2014-03-03 버밀리언, 인코포레이티드 난소암에 대한 바이오마커 패널,진단 방법 및 시험 키트
CN102735840B (zh) * 2011-04-13 2014-06-04 中国医学科学院肿瘤研究所 用于诊断或筛查卵巢癌的试剂
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
EP3216872B1 (en) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzyme quantification
US20140242612A1 (en) * 2011-07-14 2014-08-28 Shuqi Wang System and method for integration of mobile device imaging with microchip elisa
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
ES2734494T3 (es) 2011-12-08 2019-12-10 Astute Medical Inc Métodos y usos para el diagnóstico de una lesión renal y de una insuficiencia renal
WO2013119279A2 (en) * 2012-02-07 2013-08-15 Quest Diagnostics Investments Incorporated Assays and methods for the diagnosis of ovarian cancer
WO2013120089A1 (en) 2012-02-10 2013-08-15 Raindance Technologies, Inc. Molecular diagnostic screening assay
CN102621331B (zh) * 2012-04-05 2014-07-30 中国医学科学院病原生物学研究所 一种检测或辅助检测结核性胸膜炎的试剂盒
EP2844768B1 (en) 2012-04-30 2019-03-13 Raindance Technologies, Inc. Digital analyte analysis
ES2691070T3 (es) 2012-05-11 2018-11-23 Kael-Gemvax Co.,Ltd Péptidos antiinflamatorios y composición que comprende los mismos
WO2013169060A1 (ko) 2012-05-11 2013-11-14 주식회사 카엘젬백스 패혈증 예방 또는 치료용 조성물
WO2013188391A2 (en) * 2012-06-11 2013-12-19 Georgia Regents University Biomarkers for ovarian cancer
ES2981865T3 (es) 2012-07-11 2024-10-10 Gemvax & Kael Co Ltd Conjugado que comprende un péptido de penetración celular y composiciones que comprenden el mismo
JP6317763B2 (ja) * 2013-01-08 2018-04-25 シュピーンゴテック ゲゼルシャフト ミット ベシュレンクテル ハフツング 対象における癌となる危険性を予測し又は癌と診断する方法
TR201807542T4 (tr) 2013-01-17 2018-06-21 Astute Medical Inc Böbrek hasarı ve böbrek yetmezliği teşhisi ve prognozuna yönelik metotlar ve bileşimler.
KR102258864B1 (ko) 2013-04-19 2021-06-01 주식회사 젬백스앤카엘 허혈성 손상 치료 및 예방용 조성물
WO2014172288A2 (en) 2013-04-19 2014-10-23 Raindance Technologies, Inc. Digital analyte analysis
SG10201703977UA (en) 2013-05-23 2017-06-29 Five Prime Therapeutics Inc Methods of treating cancer
RU2677277C2 (ru) * 2013-06-07 2019-01-16 Джемвакс Энд Каэл Ко., Лтд. Биологические маркеры, которые могут быть использованы в иммунотерапии рака
TWI539960B (zh) 2013-06-21 2016-07-01 凱爾傑姆維克斯有限公司 激素分泌調節劑、包括其的組成物以及其用途
RU2670768C9 (ru) * 2013-06-27 2018-12-17 Цзинхуа Юниверсити Биологический маркер опухоли
CN104422768A (zh) * 2013-08-30 2015-03-18 广州瑞博奥生物科技有限公司 一种联合检测早期卵巢癌标志物的抗体芯片试剂盒
US20160291025A1 (en) * 2013-09-18 2016-10-06 Adelaide Research & Innovation Pty Ltd Autoantibody biomarkers of ovarian cancer
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
CA2926183C (en) 2013-10-23 2018-07-03 Gemvax & Kael Co., Ltd. Composition for treating and preventing benign prostatic hyperplasia
GB201319878D0 (en) * 2013-11-11 2013-12-25 Immunovia Ab Method, Array and use thereof
EP3072519B1 (en) 2013-11-22 2020-08-19 Gemvax & Kael Co., Ltd. Peptide having angiogenesis inhibitory activity and composition containing same
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
ES2809251T3 (es) 2013-12-17 2021-03-03 Gemvax & Kael Co Ltd Composición para tratar cáncer de próstata
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
EP2891884B1 (en) 2014-01-07 2017-10-25 Samsung Electronics Co., Ltd IL-8 for predicting or monitoring efficacy of c-MET inhibitor
SG11201608303QA (en) 2014-04-04 2016-11-29 Del Mar Pharmaceuticals Use of dianhydrogalactitol and analogs or derivatives thereof to treat non-small-cell carcinoma of the lung and ovarian cancer
JP6420459B2 (ja) 2014-04-11 2018-11-07 ジェムバックス アンド カエル カンパニー,リミティド 線維症抑制活性を有するペプチド及びこれを含む組成物
US10662223B2 (en) 2014-04-30 2020-05-26 Gemvax & Kael Co., Ltd. Composition for organ, tissue, or cell transplantation, kit, and transplantation method
KR102413243B1 (ko) 2014-12-23 2022-06-27 주식회사 젬백스앤카엘 안질환 치료 펩티드 및 이를 포함하는 안질환 치료용 조성물
KR102636129B1 (ko) 2015-02-27 2024-02-14 주식회사 젬백스앤카엘 청력 손상 방어용 펩타이드 및 이를 포함하는 조성물
JP7118886B2 (ja) 2015-06-03 2022-08-16 エアラン セル テクノロジーズ, インコーポレイテッド 幹細胞からの有益因子の産生および送達のための方法およびデバイス
EP3318265B1 (en) 2015-07-02 2021-08-18 Gemvax & Kael Co., Ltd. Peptide having anti-viral effect and composition containing same
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
EP4272829A3 (en) 2016-04-07 2024-01-17 Gemvax & Kael Co., Ltd. Peptide having effects of increasing telomerase activity and extending telomere, and composition containing same
JP2019515265A (ja) * 2016-04-20 2019-06-06 エーザイ インク. バイオマーカーを使用する漿液性卵巣がんの予後
EP3465201A4 (en) 2016-06-06 2020-08-26 Astute Medical, Inc. MANAGEMENT OF ACUTE KIDNEY DAMAGE USING INSULINOMIMETIC GROWTH FACTOR BINDING PROTEIN 7 AND TISSUE METALLOPROTEINASE 2 INHIBITOR
CN106520924A (zh) * 2016-10-14 2017-03-22 浙江大学 一种用于检测卵巢癌的引物组及检测方法
US20210072255A1 (en) 2016-12-16 2021-03-11 The Brigham And Women's Hospital, Inc. System and method for protein corona sensor array for early detection of diseases
JP6544697B2 (ja) * 2017-05-24 2019-07-17 株式会社Eyes, JAPAN 生体情報評価システム
US10998178B2 (en) 2017-08-28 2021-05-04 Purdue Research Foundation Systems and methods for sample analysis using swabs
CN111148844A (zh) 2017-09-01 2020-05-12 韦恩生物科技股份公司 鉴定和使用糖肽作为诊断和治疗监测的生物标记物
KR101998252B1 (ko) * 2017-12-06 2019-07-09 의료법인 성광의료재단 난소암 진단용 바이오마커 및 이의 용도
US20210318324A1 (en) 2018-07-05 2021-10-14 The Board Of Regents Of The University Of Oklahoma Gene signatures for cancer characterization and methods of use
KR20260016611A (ko) 2018-11-07 2026-02-03 시어 인코퍼레이티드 단백질 코로나 분석을 위한 조성물, 방법 및 시스템 및 그것들의 용도
EP3888021B1 (en) 2018-11-30 2024-02-21 Caris MPI, Inc. Next-generation molecular profiling
CN109557311B (zh) * 2018-12-13 2022-02-15 中南大学湘雅医院 结直肠癌诊断标志物及结直肠癌的检测产品及其应用
CN109481667A (zh) * 2018-12-14 2019-03-19 上海卡序生物医药科技有限公司 转甲状腺素蛋白在抑制肿瘤血管新生中的应用
CN109946456B (zh) * 2019-02-19 2022-02-11 中国农业科学院北京畜牧兽医研究所 牛结核病诊断标志物及其应用
JP7518852B2 (ja) 2019-03-26 2024-07-18 シアー, インコーポレイテッド 生物流体からのタンパク質コロナ分析のための組成物、方法およびシステム、ならびにそれらの使用
WO2021013783A1 (en) * 2019-07-22 2021-01-28 F. Hoffmann-La Roche Ag S100a12 as blood biomarker for the non-invasive diagnosis of endometriosis
CN117169534A (zh) 2019-08-05 2023-12-05 禧尔公司 用于样品制备、数据生成和蛋白质冠分析的系统和方法
US20240186001A1 (en) * 2019-10-16 2024-06-06 Icahn School Of Medicine At Mount Sinai Systems and methods for detecting a disease condition
WO2021107232A1 (ko) * 2019-11-29 2021-06-03 의료법인 성광의료재단 난소암 진단을 위한 바이오마커 패널을 구성하는 방법 및 난소암 진단을 위한 바이오마커 패널
CA3163319A1 (en) 2019-12-02 2021-06-10 Caris Mpi, Inc. Pan-cancer platinum response predictor
KR20230022833A (ko) * 2020-03-20 2023-02-16 아스피라 위민스 헬스 인크. 개선된 특이성 및 민감성을 갖는 난소암 평가를 위한 조성물
CN111521807B (zh) * 2020-07-02 2020-10-27 北京信诺卫康科技有限公司 Spondin 1和CA125联合用作早期卵巢癌生物标志物以及试剂盒
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof
CN111735949B (zh) * 2020-07-17 2023-07-21 北京信诺卫康科技有限公司 Wnt7a和CA125联合用作早期卵巢癌生物标志物以及试剂盒
IL300826A (en) 2020-08-25 2023-04-01 Seer Inc Compositions and methods for testing proteins and nucleic acids
EP4237090B1 (en) * 2020-10-29 2026-02-18 Board of Regents, The University of Texas System Methods for the detection and treatment of ovarian cancer
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders

Family Cites Families (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935562A (en) 1974-02-22 1976-01-27 Stephens Richard G Pattern recognition method and apparatus
US4075475A (en) 1976-05-03 1978-02-21 Chemetron Corporation Programmed thermal degradation-mass spectrometry analysis method facilitating identification of a biological specimen
US4122518A (en) 1976-05-17 1978-10-24 The United States Of America As Represented By The Administrator Of The National Aeronautics & Space Administration Automated clinical system for chromosome analysis
US4697242A (en) 1984-06-11 1987-09-29 Holland John H Adaptive computing system capable of learning and discovery
GB2187035A (en) 1986-01-27 1987-08-26 Eric James Sjoberg Pyrolysis mass spectrometer disease diagnosis aid
US4881178A (en) 1987-05-07 1989-11-14 The Regents Of The University Of Michigan Method of controlling a classifier system
US5356817A (en) 1988-06-09 1994-10-18 Yale University Methods for detecting the onset, progression and regression of gynecologic cancers
US5697369A (en) 1988-12-22 1997-12-16 Biofield Corp. Method and apparatus for disease, injury and bodily condition screening or sensing
WO1991014990A1 (en) 1990-03-28 1991-10-03 Koza John R Non-linear genetic algorithms for solving problems by finding a fit composition of functions
US5210412A (en) 1991-01-31 1993-05-11 Wayne State University Method for analyzing an organic sample
US5784162A (en) 1993-08-18 1998-07-21 Applied Spectral Imaging Ltd. Spectral bio-imaging methods for biological research, medical diagnostics and therapy
US5627040A (en) 1991-08-28 1997-05-06 Becton Dickinson And Company Flow cytometric method for autoclustering cells
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
RU2038598C1 (ru) 1992-07-06 1995-06-27 Шапиро Светлана Борисовна Способ уринодиагностики заболеваний почек
US6114114A (en) 1992-07-17 2000-09-05 Incyte Pharmaceuticals, Inc. Comparative gene transcript analysis
DE69333288T2 (de) 1992-09-01 2004-08-26 Apple Computer, Inc., Cupertino Verbesserte vektorquantisierung
US5790761A (en) 1992-12-11 1998-08-04 Heseltine; Gary L. Method and apparatus for the diagnosis of colorectal cancer
US5679719A (en) 1993-03-24 1997-10-21 Loctite Corporation Method of preparing fiber/resin composites
EP0700521B1 (en) 1993-05-28 2003-06-04 Baylor College Of Medicine Method and mass spectrometer for desorption and ionization of analytes
US5995645A (en) 1993-08-18 1999-11-30 Applied Spectral Imaging Ltd. Method of cancer cell detection
US5352613A (en) 1993-10-07 1994-10-04 Tafas Triantafillos P Cytological screening method
US5553616A (en) 1993-11-30 1996-09-10 Florida Institute Of Technology Determination of concentrations of biological substances using raman spectroscopy and artificial neural network discriminator
US6025128A (en) 1994-09-29 2000-02-15 The University Of Tulsa Prediction of prostate cancer progression by analysis of selected predictive parameters
WO1996012187A1 (en) 1994-10-13 1996-04-25 Horus Therapeutics, Inc. Computer assisted methods for diagnosing diseases
US5848177A (en) 1994-12-29 1998-12-08 Board Of Trustees Operating Michigan State University Method and system for detection of biological materials using fractal dimensions
GB2301897B (en) 1995-06-08 1999-05-26 Univ Wales Aberystwyth The Composition analysis
KR100197580B1 (ko) 1995-09-13 1999-06-15 이민화 무선 통신망을 이용한 실시간 생체신호모니터링시스템
US5716825A (en) 1995-11-01 1998-02-10 Hewlett Packard Company Integrated nucleic acid analysis system for MALDI-TOF MS
US5687716A (en) 1995-11-15 1997-11-18 Kaufmann; Peter Selective differentiating diagnostic process based on broad data bases
DE19543020A1 (de) 1995-11-18 1997-05-22 Boehringer Mannheim Gmbh Verfahren und Vorrichtung zur Bestimmung von analytischen Daten über das Innere einer streuenden Matrix
JPH09304393A (ja) * 1996-05-15 1997-11-28 Ind Technol Res Inst 急性心筋梗塞診断キット
SE9602545L (sv) 1996-06-25 1997-12-26 Michael Mecklenburg Metod för att diskriminera komplexa biologiska prover
US5839438A (en) 1996-09-10 1998-11-24 Neuralmed, Inc. Computer-based neural network system and method for medical diagnosis and interpretation
US6295514B1 (en) 1996-11-04 2001-09-25 3-Dimensional Pharmaceuticals, Inc. Method, system, and computer program product for representing similarity/dissimilarity between chemical compounds
US6571227B1 (en) 1996-11-04 2003-05-27 3-Dimensional Pharmaceuticals, Inc. Method, system and computer program product for non-linear mapping of multi-dimensional data
EP1164203B1 (en) 1996-11-06 2007-10-10 Sequenom, Inc. DNA Diagnostics based on mass spectrometry
NO308755B1 (no) * 1996-12-20 2000-10-23 Iystein Fodstad FremgangsmÕte til karakterisering av unormale celler, anvendelse og sett for utførelse av fremgangsmÕten
US6157921A (en) 1998-05-01 2000-12-05 Barnhill Technologies, Llc Enhancing knowledge discovery using support vector machines in a distributed network environment
IL131843A (en) 1997-03-24 2004-06-20 Univ Kingston A method for detecting coincidences, products and devices
US5905258A (en) 1997-06-02 1999-05-18 Advanced Research & Techology Institute Hybrid ion mobility and mass spectrometer
NZ516848A (en) 1997-06-20 2004-03-26 Ciphergen Biosystems Inc Retentate chromatography apparatus with applications in biology and medicine
US6081797A (en) 1997-07-09 2000-06-27 American Heuristics Corporation Adaptive temporal correlation network
US5974412A (en) 1997-09-24 1999-10-26 Sapient Health Network Intelligent query system for automatically indexing information in a database and automatically categorizing users
HUP0101285A2 (hu) 1998-02-13 2001-08-28 Oxford Glycosciences (Uk) Ltd. Eljárások és készítmények a hepatóma diagnosztizálására
GB9805477D0 (en) 1998-03-13 1998-05-13 Oxford Glycosciences Limited Methods and compositions for diagnosis of rheumatoid arthritis
US6085576A (en) 1998-03-20 2000-07-11 Cyrano Sciences, Inc. Handheld sensing apparatus
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
JP2002514762A (ja) 1998-05-09 2002-05-21 アイコニシス,インコーポレーテッド コンピュータによって制御された、胎児細胞を含む希少細胞に基づく診断のための方法および装置
WO2000025192A2 (en) 1998-10-26 2000-05-04 Visionary Medical, Inc. Prescription-controlled data collection system and method
US5989824A (en) 1998-11-04 1999-11-23 Mesosystems Technology, Inc. Apparatus and method for lysing bacterial spores to facilitate their identification
US20060134637A1 (en) 1999-01-06 2006-06-22 Chondrogene Limited Method for the detection of cancer related gene transcripts in blood
WO2000049410A2 (en) 1999-02-16 2000-08-24 The Government Of The United States Of America, As Represented By The Secretary Department Of Health & Human Services, The National Institutes Of Health Lcm (laser capture microdissection) for cellular protein analysis
GB9905817D0 (en) 1999-03-12 1999-05-05 Oxford Glycosciences Uk Ltd Methods
US6631333B1 (en) 1999-05-10 2003-10-07 California Institute Of Technology Methods for remote characterization of an odor
EP1336107B1 (en) * 1999-07-14 2009-01-07 Spectral Diagnostics Inc. Preparation of spheres for diagnostic tests
US7057168B2 (en) 1999-07-21 2006-06-06 Sionex Corporation Systems for differential ion mobility analysis
US6329652B1 (en) 1999-07-28 2001-12-11 Eastman Kodak Company Method for comparison of similar samples in liquid chromatography/mass spectrometry
US6615199B1 (en) 1999-08-31 2003-09-02 Accenture, Llp Abstraction factory in a base services pattern environment
WO2001020043A1 (en) 1999-09-17 2001-03-22 Affymetrix, Inc. Method of cluster analysis of gene expression profiles
WO2001031579A2 (en) 1999-10-27 2001-05-03 Barnhill Technologies, Llc Methods and devices for identifying patterns in biological patterns
WO2001031580A2 (en) 1999-10-27 2001-05-03 Biowulf Technologies, Llc Methods and devices for identifying patterns in biological systems
DE10021737C2 (de) 2000-05-04 2002-10-17 Hermann Haller Verfahren und Vorrichtung zur qualitativen und/oder quantitativen Bestimmung eines Protein- und/oder Peptidmusters einer Flüssigkeitsprobe, die dem menschlichen oder tierischen Körper entnommen wird
US20030232399A1 (en) 2000-06-14 2003-12-18 Robertson John Forsyth Russell Cancer detection methods and reagents
CN1249620C (zh) 2000-06-19 2006-04-05 科雷洛吉克系统公司 分类试探方法
WO2002006827A1 (en) 2000-07-05 2002-01-24 The General Hospital Corporation Compounds and methods for fluorescently labeling nucleic acids
US6680203B2 (en) 2000-07-10 2004-01-20 Esperion Therapeutics, Inc. Fourier transform mass spectrometry of complex biological samples
WO2002007064A2 (en) 2000-07-17 2002-01-24 Labnetics, Inc. Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities
US6925389B2 (en) 2000-07-18 2005-08-02 Correlogic Systems, Inc., Process for discriminating between biological states based on hidden patterns from biological data
AU2002245043B2 (en) 2000-11-16 2006-10-26 Bio-Rad Laboratories, Inc. Method for analyzing mass spectra
WO2002059822A2 (en) 2001-01-24 2002-08-01 Biowulf Technologies, Llc Methods of identifying patterns in biological systems and uses thereof
WO2002061047A2 (en) 2001-02-01 2002-08-08 Ciphergen Biosystems, Inc. Improved methods for protein identification, characterization and sequencing by tandem mass spectrometry
US7299134B2 (en) 2001-02-16 2007-11-20 Bio-Rad Laboratories, Inc. Method for correlating gene expression profiles with protein expression profiles
CN1463291A (zh) 2001-04-19 2003-12-24 赛弗根生物系统股份有限公司 用质谱法和亲和标记物鉴定生物分子的特性
US20020160420A1 (en) 2001-04-30 2002-10-31 George Jackowski Process for diagnosis of physiological conditions by characterization of proteomic materials
EP1421381A1 (en) 2001-08-03 2004-05-26 The General Hospital Corporation System, process and diagnostic arrangement establishing and monitoring medication doses for patients
WO2003017177A2 (en) 2001-08-13 2003-02-27 Beyong Genomics, Inc. Method and system for profiling biological systems
AU2002365228A1 (en) 2001-11-09 2003-09-02 Brad Nelson Antigen panels and methods of using the same
US20040002067A1 (en) 2001-12-21 2004-01-01 Erlander Mark G. Breast cancer progression signatures
US20050214760A1 (en) * 2002-01-07 2005-09-29 Johns Hopkins University Biomarkers for detecting ovarian cancer
WO2003062824A1 (en) 2002-01-23 2003-07-31 Boditech Inc. Lateral flow quantitative assay method and strip and laser-induced fluoerescence detection device therefor
US20020193950A1 (en) 2002-02-25 2002-12-19 Gavin Edward J. Method for analyzing mass spectra
WO2004011905A2 (en) 2002-07-29 2004-02-05 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
KR101107765B1 (ko) * 2002-08-06 2012-01-25 싸이퍼젠 바이오시스템즈, 인코포레이티드 난소암의 검출을 위한 생물 마커의 용도
AU2003269837B9 (en) * 2002-09-26 2009-07-30 Hvidovre Hospital A method for detecting, screening and/or monitoring a cancer in an individual
JP4585167B2 (ja) 2002-11-29 2010-11-24 東芝医用システムエンジニアリング株式会社 X線コンピュータ断層撮影システム
CA2516591A1 (en) 2003-02-26 2004-09-10 Mount Sinai Hospital Multiple marker assay for detection of ovarian cancer
US7311665B2 (en) 2003-05-19 2007-12-25 Alcohol Monitoring Systems, Inc. Bio-information sensor monitoring system and method
BRPI0413190A (pt) 2003-08-01 2006-10-03 Correlogic Systems Inc múltiplas caracterìsticas proteÈmicas séricas de alta resolução para detecção de cáncer de ovário
US20070042405A1 (en) * 2003-08-15 2007-02-22 University Of Pittsburgh -Of The Commonwealth System Of Higher Education Enhanced diagnostic multimarker serological profiling
AU2004264948A1 (en) 2003-08-15 2005-02-24 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Multifactorial assay for cancer detection
GB0324656D0 (en) * 2003-10-22 2003-11-26 Celltech R&D Ltd A protein involved in ovarian cancer
CA2548842A1 (en) 2003-12-11 2005-07-07 Correlogic Systems, Inc. Method of diagnosing biological states through the use of a centralized, adaptive model, and remote sample processing
JP4912894B2 (ja) * 2004-02-19 2012-04-11 イェール ユニバーシティー プロテオーム技術を使用した癌タンパク質バイオマーカーの同定
WO2005098446A2 (en) * 2004-03-31 2005-10-20 The Johns Hopkins University Biomarkers for ovarian cancer
EP1735619A4 (en) 2004-04-01 2007-09-26 Rules Based Medicine Inc UNIVERSAL FLICK TESTING
IL163061A (en) 2004-07-15 2007-07-24 Meddynamics Ltd System and method for administration of on-line healthcare
JP2008530555A (ja) 2005-02-09 2008-08-07 コレロジック システムズ,インコーポレイテッド 細菌及び芽胞の同定
US7510842B2 (en) 2005-03-11 2009-03-31 Vermilllion, Inc. Biomarker for ovarian and endometrial cancer: hepcidin
CN101243319B (zh) * 2005-06-22 2016-01-06 约翰·霍普金斯大学 卵巢癌的生物标记:ctap3-相关蛋白质
WO2007002535A2 (en) * 2005-06-24 2007-01-04 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer
EP1904852A2 (en) * 2005-06-24 2008-04-02 Ciphergen Biosystems, Inc. Biomarkers for ovarian cancer: beta-2 microglobulin
CN101268369A (zh) 2005-06-29 2008-09-17 儒勒斯贝斯特医药有限公司 诊断急性冠状动脉综合症的方法和试剂盒
CA2622332A1 (en) 2005-09-15 2007-03-22 Val-Chum, S.E.C. Methods of diagnosing ovarian cancer and kits therefor
JP4692200B2 (ja) * 2005-10-06 2011-06-01 横河電機株式会社 化学処理用カートリッジおよびその使用方法
WO2008048508A2 (en) 2006-10-13 2008-04-24 Vermillion, Inc. Prognostic biomarkers in patients with ovarian cancer
US8664358B2 (en) 2007-06-29 2014-03-04 Vermillion, Inc. Predictive markers for ovarian cancer

Also Published As

Publication number Publication date
EP2637020A3 (en) 2014-01-08
JP2010532484A (ja) 2010-10-07
CA2691980C (en) 2022-05-10
KR101262202B1 (ko) 2013-05-16
KR20100062996A (ko) 2010-06-10
CN101855553B (zh) 2014-06-11
WO2009006439A1 (en) 2009-01-08
SG182976A1 (en) 2012-08-30
EP2171453A1 (en) 2010-04-07
US20160245818A1 (en) 2016-08-25
US9846158B2 (en) 2017-12-19
EP2637020A2 (en) 2013-09-11
US8664358B2 (en) 2014-03-04
US20200256874A1 (en) 2020-08-13
KR20120087885A (ko) 2012-08-07
EP2171453A4 (en) 2010-10-06
US20180074064A1 (en) 2018-03-15
US20140221240A1 (en) 2014-08-07
US20090004687A1 (en) 2009-01-01
US10605811B2 (en) 2020-03-31
MY150234A (en) 2013-12-31
US9274118B2 (en) 2016-03-01
CA2691980A1 (en) 2009-01-08
CN101855553A (zh) 2010-10-06

Similar Documents

Publication Publication Date Title
BRPI0813002A2 (pt) marcadores preditivos para o câncer ovariano
PT2456889E (pt) Marcadores para o cancro do endométrio
DK2115472T3 (da) Cancerbiomarkører
EP2162552A4 (en) BIOMARKER FOR MELANOME
EP2186372A4 (en) FEMTO-BTS RF ACCESS MECHANISM
BRPI0810984A2 (pt) Micro-descanso extendido para comunicação
EP2223511A4 (en) sliding mechanism
BRPI0820020A2 (pt) Material anticorrosão
FI20095373L (fi) Antenni
CR10705A (es) Anticuerpos para linfotoxina-alfa
EP2210099A4 (en) BIOMARKER FOR OVARIAL CARCINOMA
BRPI0815415A2 (pt) Marcador preditivo para tratamento inibidor de egfr
BRPI0811097A2 (pt) Inibidores de raf para o tratamento de câncer de tireoide
BRPI0812572A2 (pt) Catraca
ES1066327Y (es) Dispositivo de guiado para paneles expositores
BRPI0815545A2 (pt) Marcadores preditivos para o tratamento com inibidores de egfr
BRPI0814257A2 (pt) marcador preditivo para o tratamento do inibidor de egfr
ES1064720Y (es) Guia para persiana
ES1064958Y (es) Soporte para mechero
ES1065835Y (es) Caperuza para cetreria
ES2395881T9 (es) Marcador predictivo para el tratamiento de inhibidor de EGFR
ES1066304Y (es) Bisagra para canapes
ES1066798Y (es) Bancada para vehiculos slot
BRPI0815546A2 (pt) Marcador preditivo para tratamento com inibidor da egfr
ES1063735Y (es) Testero para persiana

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL

B350 Update of information on the portal [chapter 15.35 patent gazette]